Refractory Behçet disease succesfully treated with roflumilast

Clin Exp Dermatol. 2023 Aug 25;48(9):1060-1062. doi: 10.1093/ced/llad189.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminopyridines / therapeutic use
  • Behcet Syndrome* / drug therapy
  • Benzamides / therapeutic use
  • Cyclopropanes / therapeutic use
  • Humans

Substances

  • Roflumilast
  • Aminopyridines
  • Benzamides
  • Cyclopropanes